By 2026, the global framework for drug safety monitoring has undergone a radical shift from reactive reporting to predictive prevention. The Pharmacovigilance sector is currently defined by the integration of large-scale automation and real-time biological data streams. This evolution ensures that therapeutic safety is no longer a static milestone but a continuous, dynamic process...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt